Solmone, Mariacarmela <br/><br/>
Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants.  [electronic resource] 

 -  Antiviral therapy  2014 
 - 201-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP2700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--therapeutic use<br/>Genotype<br/>Guanine--analogs & derivatives<br/>Hepatitis B virus--classification<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Middle Aged<br/>Phylogeny<br/>Viral Load